First Quadrant’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-672
| Closed | -$39K | – | 749 |
|
|
2020
Q1 | $39K | Buy |
+672
| New | +$39K | 0.01% | 552 |
|
|
2019
Q1 | – | Sell |
-5,695
| Closed | -$338K | – | 729 |
|
|
2018
Q4 | $338K | Sell |
5,695
-3,284
| -37% | -$195K | 0.03% | 425 |
|
|
2018
Q3 | $591K | Hold |
8,979
| – | – | 0.01% | 463 |
|
|
2018
Q2 | $453K | Hold |
8,979
| – | – | 0.01% | 504 |
|
|
2018
Q1 | $473K | Sell |
8,979
-3,329
| -27% | -$175K | 0.01% | 491 |
|
|
2017
Q4 | $572K | Buy |
12,308
+8,431
| +217% | +$392K | 0.01% | 520 |
|
|
2017
Q3 | $157K | Buy |
+3,877
| New | +$157K | ﹤0.01% | 745 |
|
|
2014
Q2 | – | Sell |
-52,100
| Closed | -$1.32M | – | 810 |
|
|
2014
Q1 | $1.32M | Buy |
52,100
+11,600
| +29% | +$293K | 0.03% | 343 |
|
|
2013
Q4 | $931K | Buy |
40,500
+37,400
| +1,206% | +$860K | 0.02% | 392 |
|
|
2013
Q3 | $59K | Buy |
+3,100
| New | +$59K | ﹤0.01% | 659 |
|